00:21 , Jun 23, 2017 |  BC Extra  |  Clinical News

Paper describes Affiris' PCSK9 vaccine's efficacy

In a paper published in the European Heart Journal, researchers at Affiris AG (Vienna, Austria) showed a vaccine against PCSK9 reduced cholesterol levels and atherosclerosis in mice. The vaccine, AT04A, consisted of a peptide mimic of...
00:19 , Jun 24, 2016 |  BC Extra  |  Financial News

Affiris raises EUR 10M

Affiris AG (Vienna, Austria) said it raised EUR 10 million ($11.3 million) from FCPB Affi GmbH and existing investors Santo Holding GmbH and MIG Funds. Affiris expects Phase I data in 1Q17 for AT04A and...